Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer

Gemcitabine is a principal chemotherapeutic agent for biliary tract cancer (BTC). Expression of human equilibrative nucleoside transporter 1 (hENT1) is regarded as a potential predictive biomarker for a gemcitabine response in some cancers. This study was conducted to investigate the association bet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Kim, Jaihwan, Kim, Haeryoung, Lee, Jong-chan, Kim, Jin Won, Paik, Woo Hyun, Lee, Sang Hyub, Hwang, Jin-Hyeok, Ryu, Ji Kon, Kim, Yong-Tae
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6296552/
https://ncbi.nlm.nih.gov/pubmed/30557411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0209104
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars